tiprankstipranks
NKGen Biotech announces presentation of two posters in AD
PremiumThe FlyNKGen Biotech announces presentation of two posters in AD
3M ago
NKGen Biotech Welcomes New Directors and Assigns Committees
Premium
Company Announcements
NKGen Biotech Welcomes New Directors and Assigns Committees
4M ago
NKGen Biotech Announces Leadership Shuffle on Anniversary
Premium
Company Announcements
NKGen Biotech Announces Leadership Shuffle on Anniversary
4M ago
NKGen Biotech receives noncompliance notice from Nasdaq
PremiumThe FlyNKGen Biotech receives noncompliance notice from Nasdaq
5M ago
NKGen Biotech COO Pierre Gagnon Steps Down, Remains Advisor
Premium
Company Announcements
NKGen Biotech COO Pierre Gagnon Steps Down, Remains Advisor
5M ago
NKGen Biotech presents new SNK01 biomarker data
Premium
The Fly
NKGen Biotech presents new SNK01 biomarker data
6M ago
NKGen Biotech publishes phase 1 interim data of SNK02 at ASCO
PremiumThe FlyNKGen Biotech publishes phase 1 interim data of SNK02 at ASCO
8M ago
NKGen Biotech’s SNK01 NK Cell Therapy cleared to start Phase 2 trial
Premium
The Fly
NKGen Biotech’s SNK01 NK Cell Therapy cleared to start Phase 2 trial
9M ago
NKGen Biotech announces upcoming presentation on NK Cell Therapy
Premium
The Fly
NKGen Biotech announces upcoming presentation on NK Cell Therapy
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100